CD8A and neoplasm: While there was no statistical difference between the levels of infiltrating CD3+ or CD3+ CD8+ cells within intracranial CT-2A tumours, we observed a robust increase of CD3+ and CD3+ CD8+ cells expressing the immune checkpoint, PD-1 (Fig. 4b; Supplementary Fig. 10).